HOUSEY PHARMACEUTICAL RESEARCH LAB

Address

16800 W 12 MILE RD, STE 201
SOUTHFIELD, MI, -

Information

DUNS: 611659819
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS-2 Dependent Insulin Signaling Cascade.

    Amount: $170,341.00

    DESCRIPTION provided by applicant This is a Phase I SBIR Application entitled andquot Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  2. Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).

    Amount: $239,005.00

    DESCRIPTION provided by applicant This is a Phase I SBIR Application entitled andquot Novel Inhibitors of Multi Drug Resistant Mutants of BCR ABL for the Treatment of Chronic Myelogenous Leukemia ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. Discovery and Development of Anti-Diabetic Drugs.

    Amount: $2,905,013.00

    DESCRIPTION (provided by applicant): This is a Resubmission of an NIH Phase II SBIR Renewal Application directed towards developing and optimizing compounds that are capable of stimulating IRS2 founda ...

    SBIRPhase II2011Department of Health and Human Services
  4. Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous

    Amount: $149,616.00

    DESCRIPTION (provided by applicant): This is the Phase 1 application of an SBIR proposal entitled Novel Inhibitors for the Treatment of Highly Drug Resistant Chronic Myelogenous Leukemia. The overal ...

    SBIRPhase I2009Department of Health and Human Services
  5. Discovery and Development of Antidiabetic Drugs

    Amount: $852,467.00

    DESCRIPTION (provided by applicant): This is the Phase 2 application entitled "Discovery and Development of Antidiabetic Drugs." The goal is to identify new molecular entities that promote the IRS2-br ...

    SBIRPhase II2006Department of Health and Human Services
  6. Discovery and development of Antidiabetic Drugs

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): This Phase I SBIR application entitled "Discovery and Development of Antidiabetic Drugs," proposes to establish assay systems to identify and validate small molecu ...

    SBIRPhase I2003Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government